One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry

ULISSE is the observational, multicenter, national registry evaluating all patients undergoing PCI with the Ultimaster® BP-SES. The study was designed to confirm, in a large population of 1,660 unselected patients enrolled in 9 Italian cardiology Centers, the promising results of Ultimaster® biodegradable polymer sirolimus-eluting stent (BP-SES) already shown in previous trial.

The results show that the Ultimaster® BP-SES real-world performance was comparable with that observed in the clinical trial, with low rate of primary endpoint and target lesion revascularization (TLR). Long term follow-up will be necessary to prove the theoretical advantage of the BP-SES over time.

Reference

1. Godino C, Beneduce A, Ferrante G, Ielasi A, Pivato AC, Chiarito M, Cappelletti A, Perfetti G, Magni V, Prati E, Falcone S, Pierri A, De Martini S, Montorfano M, Parisi R, Rutigliano D, Locuratolo N, Anzuini A, Tespilli M, Margonato A, Benassi A, Briguori C, Fabbiocchi F, Reimers B, Bartorelli A, Colombo A. One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry). Int J Cardiol 2018 Jun 1;260:36-41 Go to PubMed